Carbamazepine
Sodium channel stabiliser in USP/EP/BP grade for oral tablet and extended-release formulation manufacturing. Sourced for partial and generalised tonic-clonic seizure, and trigeminal neuralgia product lines.
Pharmaceutical & Life Science Solutions
Sodium channel blockers and GABAergic agents controlling seizure threshold and frequency. Supplied in USP/EP/BP/IP grade for oral solid-dose manufacturing across epilepsy and neuropathic pain product lines.
Sodium channel stabiliser in USP/EP/BP grade for oral tablet and extended-release formulation manufacturing. Sourced for partial and generalised tonic-clonic seizure, and trigeminal neuralgia product lines.
Hydantoin sodium channel blocker supplied as sodium salt — the standard pharmacopoeial trading form, USP/EP/BP/IP grade — for oral capsule and injectable formulation manufacturing.
GABA analogue free-base API in USP/EP/BP grade for oral capsule and tablet formulation manufacturing. Sourced for neuropathic pain, epilepsy adjunct, and generalised anxiety disorder product lines.
Triazole-derivative anticonvulsant in pharmaceutical grade for oral tablet formulation manufacturing. Sourced for Lennox-Gastaut syndrome adjunctive seizure therapy product lines. Note: formal USP/EP monograph not confirmed — verify grade with supplier.
Sodium salt of valproic acid — a distinct compound from the free acid — in USP/EP/BP/IP grade for oral tablet, syrup, and extended-release formulation manufacturing. Sourced for epilepsy and bipolar disorder product lines.
Fructopyranose sulphamate anticonvulsant in USP/EP grade for oral tablet and sprinkle capsule formulation manufacturing. Sourced for partial/generalised epilepsy and migraine prophylaxis product lines.